Clinical Trial

CharacterIzation of Adult Onset Autoimmune Diabetes

Study acronym: CIAO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to identify new biomarkers of Adult Onset Autoimmune Diabetes (AOnAD).
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2019-05-30; most recent amendment 2026-03-25.
Status change: Recruiting → Active, Not Recruiting 2022-04-12
Status change: Not Yet Recruiting → Recruiting 2019-07-11
Trial Details
NCT Number NCT03971955
Lead Sponsor AdventHealth Translational Research Institute
Conditions Diabetes
Enrollment 25 participants
Start Date 2019-07-08
Primary Completion 2021-11-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-30